KRAS and familial pancreatic carcinoma: Cullis et al. (Cullis et al., 2018) showed that mutations in KRAS are an important cause of the immunosuppressive state of tumours, as mutations in KRAS impair recognition of pancreatic cancer cells by T cells to result in immune evasion (Cullis et al., 2018).